Last reviewed · How we verify

NCT02937649: BOUST

Bougie Sleeve Trial

Recruiting now NA Last updated 6 April 2025
What this trial tests

NA trial testing Laparoscopic sleeve gastrectomy using 48-Fr bougie in Morbid Obesity in 1,658 participants. Currently enrolling.

Timeline
8 October 2020
Primary endpoint
8 June 2025
8 September 2027

Quick facts

Lead sponsorAssistance Publique - Hôpitaux de Paris
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment1,658
Start date8 October 2020
Primary completion8 June 2025
Estimated completion8 September 2027
Sites12 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Adults 18 to 70, any sex, with Morbid Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Staple-line leak is the most frequent and incapacitating complication after laparoscopic sleeve gastrectomy (LSG). The aim of this prospective randomized trial is to compare the staple-line leak rate after LSG according to the use of a standard bougie calibre (34, 36 or 38 Fr) or 48-Fr, assuming that a higher diameter is correlated with a lower risk of leak, without lowering long-term weight loss.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of the calibration bougie diametre during laparoscopic sleeve gastrectomy on the rate of postoperative staple-line leak (BOUST): study protocol for a multicentre randomized prospective trial.
    Gaillard M, Lainas P, Agostini H, Dagher I, et al · · 2021 · cited 2× · PMID 34781991 · DOI 10.1186/s13063-021-05734-3

Verify or expand the search:

Other recruiting trials for Morbid Obesity

Currently open trials in the same condition.

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02937649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing